Nasdaq Investment Intelligence ChannelPfizer-BioNTech COVID-19 Vaccine Garners Full FDA ApprovalBy Karrie GordonAugust 24, 2021
Nasdaq Investment Intelligence Channel‘QQQA’ Won’t Miss Its Shot as Pfizer and Moderna Set to Profit with BoostersBy Karrie GordonAugust 13, 2021
FeaturedNew CDC Covid-19 Guidance Spooks Stocks While Boosting Inverse Stock ETFsBy Ian YoungJuly 27, 2021
Thematic Investing ChannelWith COVID Still Front and Center, WFH Stocks and ‘CLOU’ Keep ClimbingBy Ben HernandezApril 15, 2021